Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

5.38p
   
  • Change Today:
    -0.25p
  • 52 Week High: 22.25
  • 52 Week Low: 3.13
  • Currency: UK Pounds
  • Shares Issued: 143.14m
  • Volume: 1,268,108
  • Market Cap: £7.69m
  • RiskGrade: 747

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
14.41% above the market average14.41% above the market average14.41% above the market average14.41% above the market average14.41% above the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
89.18% above the market average89.18% above the market average89.18% above the market average89.18% above the market average89.18% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Book Ratio
72.75% below the market average72.75% below the market average72.75% below the market average72.75% below the market average72.75% below the market average
56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
98.81% above the market average98.81% above the market average98.81% above the market average98.81% above the market average98.81% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Chg 3m
80.02% below the market average80.02% below the market average80.02% below the market average80.02% below the market average80.02% below the market average
72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
53.49% above the market average53.49% above the market average53.49% above the market average53.49% above the market average53.49% above the market average
52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average
Momentum 20
38.74% above the market average38.74% above the market average38.74% above the market average38.74% above the market average38.74% above the market average
70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
98.11% below the market average98.11% below the market average98.11% below the market average98.11% below the market average98.11% below the market average
93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
76.81% below the market average76.81% below the market average76.81% below the market average76.81% below the market average76.81% below the market average
43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average
Operating Profit Loss
70.61% below the market average70.61% below the market average70.61% below the market average70.61% below the market average70.61% below the market average
37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
61.42% below the market average61.42% below the market average61.42% below the market average61.42% below the market average61.42% below the market average
68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average
Cash
40.62% below the market average40.62% below the market average40.62% below the market average40.62% below the market average40.62% below the market average
56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genedrive Market Data

Currency UK Pounds
Share Price 5.38p
Change Today -0.25p
% Change -4.44 %
52 Week High 22.25
52 Week Low 3.13
Volume 1,268,108
Shares Issued 143.14m
Market Cap £7.69m
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
42.05% below the market average42.05% below the market average42.05% below the market average42.05% below the market average42.05% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average
Price Trend
90.82% below the market average90.82% below the market average90.82% below the market average90.82% below the market average90.82% below the market average
72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average
Income Not Available
Growth
44.82% below the market average44.82% below the market average44.82% below the market average44.82% below the market average44.82% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average

Genedrive Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
16:29 36 @ 5.50p
16:21 5,000 @ 5.45p
16:07 4,956 @ 5.28p
15:30 94,320 @ 5.31p
14:37 2,000 @ 5.50p

Genedrive Key Personnel

CFO Russell Shaw
CEO James Cheek

Top of Page